Bisdemethoxycurcumin (BDMC) is one of three curcuminoids extracted from turmeric. Unlike the dominant ingredient curcumin with some intensive investigations, BDMC was recently reported to possess potent antitumor, anti-inflammatory, antiatherosclerosis, antiobesity, and antiaging effects. Considering its pharmacological effects in inflammation, atherosclerosis, and obesity, this study was designed to examine if BDMC displays cardioprotective properties. In this study, staurosporine (STS) was used to establish the cardiomyocyte injury model. Our data revealed that BDMC significantly inhibited myocardial apoptosis, improved cell survival, reduced caspase-3 activity, and diminished reactive oxygen species (ROS) production. BDMC enhanced phosphorylation of protein kinase B (AKT) and extracellular signal-regulated kinase (ERK) and up-regulated the expression of HO-1. Inhibition of HO-1 activity by using tin-protoporphyrin (SnPPIX) can restrain the antiapoptotic effect of BDMC. Furthermore, translocation of Nrf2 from the cytoplasm to the nucleus was ablated by LY294002, although only partially by PD98059. Up-regulation of HO-1 was weakly suppressed by PD98059 but strongly inhibited by LY294002. Unlike PD98059, LY294002 negated the protective effect of BDMC. These findings indicated that BDMC possessed favorable cardioprotection in a Nrf2/HO-1-dependent manner. Activation of Nrf2/HO-1 mainly depended on PI3K/AKT but not MEK/ERK signaling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.chemrestox.9b00222 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bisdemethoxycurcumin mitigates traumatic brain injury in rats by modulating autophagy and oxidative stress via heat shock protein 90 alpha family class A member 1-mediated nuclear translocation of transcription factor EB.
Brain Res Bull
January 2025
The First Affiliated Hospital, Department of Critical Care Medicine, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Hengyang, 421001, Hunan Province, People's Republic of China. Electronic address:
Background: Bisdemethoxycurcumin (BDMC), the primary active compound found in turmeric, exhibits diverse pharmacological properties. The study aimed to investigate the mechanisms underlying the protective effects of BDMC in traumatic brain injury (TBI).
Methods: A rat TBI model was established using the Feeney's freefall epidural impact method, followed by BDMC treatment.
Study on the Therapeutic Effects of Bisdemethoxycurcumin on a Cerebral Amyloid Angiopathy Mouse Model Established via Chronic Treatment With Five Vascular Risk Factors.
Brain Behav
January 2025
Department of Neurology, The First Affiliated Hospital, Multi-Omics Research Center for Brain Disorders, Hengyang Medical School, University Of South China, Hengyang, Hunan, China.
Background And Purpose: Cerebral amyloid angiopathy (CAA) is recognized as a major contributor to progressive cognitive decline and cerebral hemorrhages in the elderly population. Currently, there is a global shortage of safe and effective treatments for this condition. Bisdemethoxycurcumin (BDMC) has been demonstrated to exhibit pharmacological effects with anti-Aβ toxicity properties.
View Article and Find Full Text PDFBisdemethoxycurcumin, a novel potent polyphenolic compound, effectively inhibits the formation of amyloid aggregates in ALS-associated hSOD1 mutant (L38R).
Int J Biol Macromol
December 2024
Department of Analytical Chemistry, Faculty of Chemistry, University of Mazandaran, Babolsar, Iran.
Protein misfolding is a biological process that leads to protein aggregation. Anomalous misfolding and aggregation of human superoxide dismutase (hSOD1) into amyloid aggregates is a characteristic feature of amyotrophic lateral sclerosis (ALS), a neurodegenerative illness. Thus, focusing on the L38R mutant may be a wise decision to comprehend the SOD1 disease process in ALS.
View Article and Find Full Text PDFInsights into inhibitory action and interaction of bisdemethoxycurcumin on tyrosinase: Spectroscopic and docking analysis.
Int J Biol Macromol
November 2024
School of Pharmacy and Food Engineering & Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, Wuyi University, Jiangmen 529020, China; Guangdong Laboratory of Chemistry and Fine Chemical Industry Jieyang Center, Jieyang 515200, China. Electronic address:
Article Synopsis
- Bisdemethoxycurcumin (BDMC) is a derivative of curcumin that shows promise as an anti-tyrosinase agent, which could be useful in food preservation and cosmetics, although its specific interactions and inhibitory mechanisms with tyrosinase are not well understood.
- This study investigates how BDMC interacts with tyrosinase using various spectroscopic techniques and evaluates its effectiveness in preventing browning in fresh-cut apples, revealing that BDMC inhibits tyrosinase in a reversible manner and has a good binding affinity.
- The findings highlight that BDMC changes the structure and activity of tyrosinase while also regulating related enzymatic activities, establishing BDMC as a potential natural anti-browning agent supported
Effects of photodynamic therapy using bisdemethoxycurcumin combined with melatonin or acetyl-melatonin on C. Albicans.
Sci Rep
October 2024
Melatonin Research Group, Khon Kaen University, Khon Kaen, Thailand.
Article Synopsis
- The study investigates the effectiveness of antifungal photodynamic therapy (PDT) using a combination of bisdemethoxycurcumin (BDMC) with melatonin (MLT) or acetyl-melatonin (AcO-MLT) against C. albicans biofilms.
- Findings showed significant reductions in colony forming units (CFUs) with specific combinations of BDMC and MLT, particularly notable at early post-treatment times.
- The research also highlights that MLT enhances singlet oxygen production, which correlates with antifungal efficacy, while BDMC showed minimal cytotoxic effects on human oral cells.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!